The global cefazolin sodium market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period (2022-2028). Several types of research for the development of antimicrobial drugs that does not get resisted by the human body are propelling the growth of the global cefazolin sodium market. For instance, the Thayer School of Engineering at Dartmouth had engineered a new bacterial agent in September 2020, for drug-resistant bacterial infections with the help of natural lysins. Similarly, the Oxford University had conducted high collaborative research in December 2021 for the discovery of a new treatment that has the ability to reverse antibiotic resistance in bacteria that causes sepsis, pneumonia, and urinary tract infections with the help of carbapenems, by producing enzymes called Metallo-beta-lactamases (MBLs) that break down the carbapenem antibiotics, stopping them from working.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cefazolin-sodium-market
The market players are also contributing significantly to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new vaccine launches for the advancement of the disease treatment, to stay competitive in the market. For instance, the Premier Inc. had partnered with Apotex Corp. in February 2021, to supply three major antibiotics to healthcare providers. This was done to secure the immediate and long-term supply of antibiotics medication to treat bacterial infections.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2022
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape – including CSPC Pharmaceutical Group Ltd., Dun& Bradstreet, Inc., HISUN USA Ltd., Pfizer Inc., LKPC Pharmaceutical Co. Ltd., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Cefazolin Sodium Market Report Segment
By Type
- Antimicrobial Drug
- Cephalosporins
- First Generation Cephalosporins
By End-User
- Adults
- Children
A full report of Cefazolin Sodium Market is available at: https://www.omrglobal.com/industry-reports/cefazolin-sodium-market
Cefazolin Sodium Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Acs Dobfar S.p.A
- Fresenius SE & Co. KGaA
- HPGC
- LKPC Pharmaceutical Co. Ltd.
- North China Pharmaceutical Group Ltd.
- Orchid Pharma Ltd.
- Olon S.p.A.
- Qilu Pharmaceutical Co. Ltd.
- Shandong Lukang Pharmaceutical Co. Ltd.
- Souguang Fukang Pharmaceutical Co. Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
